Kashiwagi T - Search Results

1

Restoration of innate and adaptive immune responses by HCV viral inhibition with an induction approach using natural interferon-beta in chronic hepatitis C.

Kishida Y, Imaizumi N, Tanimura H, Haruna Y, Kashiwamura S, Kashiwagi T. Kishida Y, et al. Among authors: kashiwagi t. Clin Dev Immunol. 2012;2012:582716. doi: 10.1155/2012/582716. Epub 2012 Aug 27. Clin Dev Immunol. 2012. PMID: 22966239 Free PMC article.

2

Predictive factors for efficacy of interferon therapy in chronic hepatitis type C.

Ishibashi K, Kashiwagi T, Ito A, Tanaka Y, Nagata T, Tamaki J, Azuma M, Kishida Y, Yoshida A, Hikiji AY. Ishibashi K, et al. Among authors: kashiwagi t. Hepatogastroenterology. 1995 Sep-Oct;42(5):535-41. Hepatogastroenterology. 1995. PMID: 8751211

3

Gastric mucosal energy metabolism and intracellular mucin content changes in patients with liver cirrhosis.

Kawano S, Tanimura H, Tsuji S, Takei Y, Nagano K, Kashiwagi T, Fusamoto H, Kamada T. Kawano S, et al. Among authors: kashiwagi t. J Gastroenterol Hepatol. 1996 Apr;11(4):380-4. doi: 10.1111/j.1440-1746.1996.tb01387.x. J Gastroenterol Hepatol. 1996. PMID: 8713706

4

Age-related change in human gastric mucosal energy metabolism.

Kawano S, Tanimura H, Sato N, Nagano K, Tsuji S, Takei Y, Tsujii M, Hayashi N, Masuda E, Kashiwagi T, et al. Kawano S, et al. Among authors: kashiwagi t. Scand J Gastroenterol. 1991 Jul;26(7):701-6. doi: 10.3109/00365529108998587. Scand J Gastroenterol. 1991. PMID: 1896811

5

Impaired gastric mucosal energy metabolism in congestive gastropathy in cirrhotic patients.

Kawano S, Tanimura H, Tsuji S, Takei Y, Nagano K, Kashiwagi T, Fusamoto H, Kamada T. Kawano S, et al. Among authors: kashiwagi t. J Gastroenterol. 1994 Jun;29(3):245-9. doi: 10.1007/BF02358361. J Gastroenterol. 1994. PMID: 8061793

6

Three-dimensional display of liver, spleen, hepatoma, and blood vessels by MR imaging and computer graphics.

Kashiwagi T, Murakami T, Azuma M, Tamaki J, Ishibashi K, Kishida Y, Takei Y, Kawano S, Fusamoto H, Kamada T, et al. Kashiwagi T, et al. Acta Radiol. 1994 Jan;35(1):88-9. Acta Radiol. 1994. PMID: 8305281

7

Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance.

Katayama K, Kasahara A, Sasaki Y, Kashiwagi T, Naito M, Masuzawa M, Katoh M, Yoshihara H, Kamada T, Mukuda T, Hijioka T, Hori M, Hayashi N. Katayama K, et al. Among authors: kashiwagi t. J Viral Hepat. 2001 May;8(3):180-5. doi: 10.1046/j.1365-2893.2001.00274.x. J Viral Hepat. 2001. PMID: 11380795 Clinical Trial.

8

Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C.

Ishibashi K, Kashiwagi T, Ito A, Tanaka Y, Nagasawa M, Toyama T, Ozaki S, Naito M, Azuma M. Ishibashi K, et al. Among authors: kashiwagi t. Hepatology. 1996 Jul;24(1):27-31. doi: 10.1053/jhep.1996.v24.pm0008707274. Hepatology. 1996. PMID: 8707274 Clinical Trial.

9

Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.

Tanaka H, Tsukuma H, Kasahara A, Hayashi N, Yoshihara H, Masuzawa M, Kanda T, Kashiwagi T, Inoue A, Kato M, Oshima A, Kinoshita Y, Kamada T. Tanaka H, et al. Among authors: kashiwagi t. Int J Cancer. 2000 Sep 1;87(5):741-9. Int J Cancer. 2000. PMID: 10925370

10

[Prolonged (24 weeks) treatment of chronic hepatitis type B with recombinant interferon-alpha].

Matsuda H, Kashiwagi T. Matsuda H, et al. Among authors: kashiwagi t. Nihon Rinsho. 1995 Oct;53 Suppl(Pt 2):629-34. Nihon Rinsho. 1995. PMID: 12442457 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters